ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
美国抗疫概念
1,341.13
-8.1082
-0.60%
涨家数:
7
跌家数:
13
平家数:
- -
市盈率:
- -
高:
1,349.81
开:
1,349.81
低:
1,326.47
收:
1,349.23
数据加载中...
总览
新闻
K药皮下剂型陷专利纠纷,罗氏再砍3条管线,阿斯利康联手3家本土药企
医药经济报
·
4小时前
辉瑞4月25日成交额为8.20亿美元
市场透视
·
4小时前
莫德纳4月25日成交额为2.11亿美元
市场透视
·
5小时前
吉利德科学4月25日成交额为14.63亿美元
市场透视
·
5小时前
阿斯利康4月25日成交额为4.62亿美元
市场透视
·
5小时前
美股抗疫概念股多数下跌,BioNTech跌超15%
每日经济新闻
·
8小时前
勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份
路透中文
·
8小时前
勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份
路透中文
·
8小时前
BUZZ-Novavax 因报告 FDA 要求对 COVID 疫苗进行新试验而下跌
路透中文
·
11小时前
据《华尔街日报》报导,美国 FDA 要求 Novavax 完成 COVID-19 延迟注射的新临床试验
路透中文
·
11小时前
据《华尔街日报》报导,FDA要求诺瓦克斯公司完成COVID-19延迟注射的新临床试验
路透中文
·
11小时前
诺瓦瓦克斯医药盘中异动 股价大跌5.73%
市场透视
·
11小时前
Nanoviricides, Inc.盘中异动 股价大涨5.19%报1.42美元
市场透视
·
昨天
吉利德科学盘中异动 早盘股价大跌3.41%
市场透视
·
昨天
Equillium, Inc.盘中异动 股价大跌5.96%
市场透视
·
昨天
吉利德科学(GILD)第一季同比扭亏为盈至13.15亿美元
金吾财讯
·
昨天
辉瑞英立达 获批国内首个且唯一晚期肾癌一线靶免联合治疗
21经济网
·
昨天
辉瑞:阿昔替尼获批中国首个且唯一晚期肾癌一线靶免联合治疗
美港电讯
·
昨天
港股异动 | 和铂医药-B(02142)再涨超4% 公司与阿斯利康合作深化 已与多家MNC达成合作协议
智通财经
·
昨天
和铂医药再涨超4%公司与阿斯利康合作深化已与多家MNC达成合作协议
动脉网
·
昨天
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1341.1263,"timestamp":1745611199999,"preClose":1349.2345,"halted":0,"volume":105403296,"delay":0,"changeRate":-0.006009,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-8.108154,"latestTime":"04-25 16:00:00 EDT","open":1349.8055,"high":1349.8055,"low":1326.4735,"amount":5679459236.570498,"amplitude":0.017293,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.698077,"peRate":24.530558,"turnoverRate":0.006797,"increases":7,"decrements":13,"flats":0,"marketCap":1107563323728.5,"floatMarketCap":1088066496974.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1349.8055,"amplitude":0.017293,"preClose":1349.2345,"low":1326.4735,"pbRate":"3.698077","latestPrice":1341.1263,"volume":105403296,"delay":0,"open":1349.8055,"prevYearClose":1274.8187,"prevWeekClose":1341.7848,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1341.7848,"twentyDayClose":1413.7192,"sixtyDayClose":1349.6512,"secType":"PLATE","market":"US","turnoverRate":0.006797,"peRate":24.530558,"marketCap":1107563323728.5,"floatMarketCap":1088066496974.5,"timestamp":1745611199999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":7,"down":13,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530114058","title":"K药皮下剂型陷专利纠纷,罗氏再砍3条管线,阿斯利康联手3家本土药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2530114058","media":"医药经济报","labels":["corporation","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530114058?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 11:02","pubTimestamp":1745636535,"startTime":"0","endTime":"0","summary":"K药皮下剂型被诉专利侵权4月24日,美国生物技术公司Halozyme在新泽西州的美国地方法院对默沙东提起专利侵权诉讼。据悉,Halozyme的MDASE皮下递送技术利用人透明质酸酶实现药物的快速、大容量皮下注射。为此,Halozyme正在寻求损害赔偿和禁令救济,以阻止默沙东的侵权行为。在肺癌领域,阿斯利康积极推动研究创新疗法,已与6家本土药企达成合作,推进8项联合治疗研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426112537a467a720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426112537a467a720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1116320901.HKD","LU1037948897.HKD","SG9999001440.SGD","LU2461242641.AUD","LU1162221912.USD","IE00B1BXHZ80.USD","LU0265550946.USD","IE00BN8TJ469.HKD","SGXZ57979304.SGD","LU1093756168.USD","IE00BLSP4452.SGD","LU0965509101.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","SG9999015341.SGD","BK4533","SG9999015358.SGD","LU1066053197.SGD","LU2023250504.SGD","LU1941712264.USD","LU1989772923.USD","MRK","LU1699723380.USD","LU1035773651.USD","LU1069347547.HKD","LU0265550359.USD","LU0266013472.USD","LU1430594728.SGD","LU0320765489.SGD","LU1934455863.HKD","IE00BJT1NW94.SGD","LU2361044949.HKD","AZN","SG9999013999.USD","LU2456880835.USD","LU1989771016.USD","LU0861579265.USD","LU2468319806.SGD","LU1934455194.USD","IE000M9KFDE8.USD","LU2361045086.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU2023250843.SGD","BK4550","LU0320765992.SGD","LU0203345920.USD","LU2361044865.SGD","LU2089984988.USD","BK4568"],"gpt_icon":0},{"id":"2530772119","title":"辉瑞4月25日成交额为8.20亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530772119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530772119?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 10:18","pubTimestamp":1745633897,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日,辉瑞成交额为8.20亿美元,成交额较昨日增加3.34%,当日成交量为3584.77万股。辉瑞于2025年4月25日涨0.61%,报22.92美元,该股过去5个交易日涨3.52%,年初至今跌12.18%,过去60日跌13.9%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|#|2025-04-23|11.45亿|41.51%|5078.10万|#|2025-04-22|8.09亿|14.76%|3605.26万|#|2025-04-21|7.05亿|-41.56%|3202.10万|辉瑞是全球最大的制药公司之一,年销售额接近500亿美元。辉瑞在全球销售这些产品,国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426101825a46793a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE000M9KFDE8.USD","BK4533","SG9999003800.SGD","BK4592","LU0289739699.SGD","BK4581","LU0225771236.USD","BK4599","LU1057294990.SGD","PFE","IE00BLSP4452.SGD","LU1894683348.USD","SG9999002232.USD","LU0234572021.USD","SG9999013999.USD","BK4568","LU1023059063.AUD","IE00BLSP4239.USD","LU1066051498.USD","LU0321505439.SGD","BK4007","SGXZ57979304.SGD","LU0321505868.SGD","LU0058720904.USD","IE0002270589.USD","LU1883839398.USD","LU0868494617.USD","SG9999002224.SGD","LU0306807586.USD","BK4588","LU1894683264.USD","LU1066053197.SGD","LU0170899867.USD","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD","LU0122379950.USD","BK4534","LU0456855351.SGD","LU0306806265.USD","SG9999001176.SGD","LU0985481810.HKD","BK4585","IE00B19Z3B42.SGD","SG9999001176.USD","IE00BBT3K403.USD","BK4550"],"gpt_icon":1},{"id":"2530197281","title":"莫德纳4月25日成交额为2.11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530197281","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530197281?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 10:02","pubTimestamp":1745632934,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日,莫德纳成交额为2.11亿美元,成交额较昨日增加62.78%,当日成交量为771.91万股。莫德纳于2025年4月25日跌0.62%,报27.22美元,该股过去5个交易日涨10.11%,年初至今跌34.54%,过去60日跌33.15%。截至 2024年9月,莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100215a6c8d01f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100215a6c8d01f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4568","BK4534","BK4533","BK4501","BK4532","BK4551","MRNA","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2530119082","title":"吉利德科学4月25日成交额为14.63亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530119082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530119082?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 09:34","pubTimestamp":1745631298,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日,吉利德科学成交额为14.63亿美元,成交额较昨日增加35.59%,当日成交量为1420.82万股。吉利德科学于2025年4月25日跌2.81%,报103.17美元,该股过去5个交易日跌1.31%,年初至今涨12.48%,过去60日涨8.69%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权,该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426093502a6c8c7b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426093502a6c8c7b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4583","LU1066053197.SGD","BK4588","BK4566","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU1571399168.USD","IE0002270589.USD","LU2089984988.USD","BK4585","LU0109394709.USD","IE00B3T34201.USD","LU1585245621.USD","LU0234570918.USD","BK4550","LU0058720904.USD","LU2087621335.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","GILD","LU1430594728.SGD","LU1066051498.USD","LU2468319806.SGD","BK4139","IE00BKVL7J92.USD","LU0320765992.SGD","BK4532","BK4568","LU1839511570.USD","IE00B19Z3581.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2530607113","title":"阿斯利康4月25日成交额为4.62亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530607113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530607113?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 09:16","pubTimestamp":1745630209,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日,阿斯利康成交额为4.62亿美元,成交额较昨日增加94.02%,当日成交量为666.27万股。阿斯利康于2025年4月25日涨0.03%,报69.57美元,该股过去5个交易日涨2.93%,年初至今涨7.91%,过去60日涨0.53%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-25|4.62亿|94.02%|666.27万|#|2025-04-24|2.38亿|-38.92%|343.21万|#|2025-04-23|3.90亿|-1.09%|567.40万|#|2025-04-22|3.94亿|128.16%|580.70万|#|2025-04-21|1.73亿|-32.74%|257.30万|1999 年,瑞典阿斯特拉公司与英国捷利康集团合并,成立了阿斯利康公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091702a467845e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091702a467845e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU2462157665.USD","LU2417539215.USD","BK4568","LU0109394709.USD","BK4585","LU2236285917.USD","BK4007","LU2456880835.USD","AZN","LU0320765992.SGD","BK4588","LU1829250122.USD"],"gpt_icon":0},{"id":"2530868192","title":"美股抗疫概念股多数下跌,BioNTech跌超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530868192","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530868192?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 06:55","pubTimestamp":1745621711,"startTime":"0","endTime":"0","summary":"每经AI快讯,4月26日,美股抗疫概念股多数下跌,Moderna跌0.62%,吉利德科学跌超2%,诺瓦瓦克斯医药跌逾5%,BioNTech跌超15%,阿斯利康涨0.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504263389420366.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504263389420366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0234570918.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","GILD","BK4568","LU1066053197.SGD","LU1585245621.USD","IE00B19Z3581.USD","LU2468319806.SGD","LU0058720904.USD","BK4547","IE00BKVL7J92.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4139","IE00B3T34201.USD","LU0109394709.USD","BK4583","LU1066051498.USD","LU2087621335.USD","BK4532","BK4550","IE0002270589.USD","BK4588","LU0289739699.SGD","BK4566","BK4578","LU2089984988.USD","BK4585","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1839511570.USD"],"gpt_icon":0},{"id":"2530196258","title":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2530196258","media":"路透中文","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530196258?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 06:09","pubTimestamp":1745618944,"startTime":"0","endTime":"0","summary":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份Svea Herbst-Bayliss路透纽约4月25日 - 熟悉内情的消息人士周五透露,亿万富翁投资者丹尼尔-勒布的对冲基金Third Point正在增持KenvueKVUE.N的股份,因为一些投资者正在推动这家消费保健品公司进行战略调整。目前还不能确定 Third Point 的投资规模有多大,也不能确定该对冲基金是否与 Kenvue 董事会或管理层进行了接触。Third Point 的一位代表拒绝发表评论。英国《金融时报》周五首次报导了 Third Point 持有 Kenvue 股份的消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R3245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU0345770993.USD","BK4524","KVUE","LU0122379950.USD","LU1221951129.SGD","LU2347655156.SGD","LU2505996509.AUD","BK4559","IE00B19Z3581.USD","LU2430703251.USD","IE00BVYPNV92.GBP","BK4568","IE00B7SZLL34.SGD","LU0203347892.USD","LU0320765489.SGD","LU2430703095.HKD","LU0114720955.EUR","LU1244550221.USD","BK4507","IE00B2B36J28.USD","LU1032466523.USD","IE00BLSP4452.SGD","LU0310800379.SGD","BBWI","LU2602419157.SGD","BK4554","LU1718418525.SGD","LU0466842654.USD","LU1074936037.SGD","JNJ","LU1162221912.USD","LU1674673428.USD","LU1732799900.SGD","LU2129689514.USD","LU0070302665.USD","LU0795875169.SGD","LU1244550494.USD","SG9999001440.SGD","LU1261432733.SGD","SG9999015952.SGD","AAP","LU1032955483.USD","LU0058720904.USD","BK4183","IE00BJT1NW94.SGD","LU1196500208.SGD","IE00BFTCPJ56.SGD","LU1585245621.USD"],"gpt_icon":1},{"id":"2530196237","title":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2530196237","media":"路透中文","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530196237?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 06:09","pubTimestamp":1745618944,"startTime":"0","endTime":"0","summary":"勒布的 Third Point 公司增持创可贴制造商 Kenvue 的股份Svea Herbst-Bayliss路透纽约4月25日 - 熟悉内情的消息人士周五透露,亿万富翁投资者丹尼尔-勒布的对冲基金Third Point正在增持KenvueKVUE.N的股份,因为一些投资者正在推动这家消费保健品公司进行战略调整。目前还不能确定 Third Point 的投资规模有多大,也不能确定该对冲基金是否与 Kenvue 董事会或管理层进行了接触。Third Point 的一位代表拒绝发表评论。英国《金融时报》周五首次报道了 Third Point 持有 Kenvue 股份的消息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4S3R3245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","IE0002270589.USD","LU0466842654.USD","SG9999015952.SGD","LU0122379950.USD","LU1261432733.SGD","BK4507","LU1162221912.USD","IE00B2B36J28.USD","BK4559","LU1221951129.SGD","LU1718418525.SGD","LU2602419157.SGD","LU0320765489.SGD","LU0070302665.USD","IE00B7SZLL34.SGD","IE00BVYPNV92.GBP","LU1196500208.SGD","LU2347655156.SGD","LU1032955483.USD","LU0203347892.USD","LU0310800379.SGD","LU2505996509.AUD","IE00BLSP4452.SGD","LU1674673428.USD","LU0795875169.SGD","LU0345770993.USD","LU2430703251.USD","BK4524","AAP","BK4183","BBWI","KVUE","JNJ","IE00B19Z3581.USD","LU1585245621.USD","SG9999001440.SGD","LU1032466523.USD","LU0114720955.EUR","BK4554","IE00BJT1NW94.SGD","LU1244550221.USD","IE00BFTCPJ56.SGD","LU1244550494.USD","LU1732799900.SGD","LU2129689514.USD","LU1074936037.SGD","LU2430703095.HKD","LU0058720904.USD"],"gpt_icon":1},{"id":"2530629031","title":"BUZZ-Novavax 因报告 FDA 要求对 COVID 疫苗进行新试验而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2530629031","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530629031?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:46","pubTimestamp":1745610380,"startTime":"0","endTime":"0","summary":"4月25日 - ** 疫苗生产商 Novavax NVAX.O 的股价在下午的交易中下跌 6.6% 至 6.61 美元** 华尔街日报》援引熟悉内情的人士的话报导称,尽管此前COVID-19疫苗的有效率达到了90%,但美国食品和药物管理局仍要求Novavax为其COVID-19疫苗再进行一次临床试验。** 周三,NOVAX称,如果COVID-19疫苗获得全面批准,美国食品和药物管理局要求该公司提供更多数据, 。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R31V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4547","BK4588","BK4139","NVAX","BK4585"],"gpt_icon":1},{"id":"2530623691","title":"据《华尔街日报》报导,美国 FDA 要求 Novavax 完成 COVID-19 延迟注射的新临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2530623691","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530623691?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:40","pubTimestamp":1745610029,"startTime":"0","endTime":"0","summary":"更新版 4-据《华尔街日报》报导,美国 FDA 要求 Novavax 完成 COVID-19 延迟注射的新临床试验在第 4 和第 5 段中添加了 Novavax 公司的评论意见据《华尔街日报》报导,FDA 要求对 COVID-19 注射剂进行新的试验Novavax 股票收盘下跌近 6. 路透4月25日 - 据《华尔街日报》周五援引知情人士的话报导,在此前推迟批准COVID-19疫苗后,联邦监管机构要求Novavax NVAX.O完成一项额外的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7884860a095da688d55e8f59fb0acbc9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R31UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","BK4547","BK4568","NVAX"],"gpt_icon":1},{"id":"2530644271","title":"据《华尔街日报》报导,FDA要求诺瓦克斯公司完成COVID-19延迟注射的新临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2530644271","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530644271?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:30","pubTimestamp":1745609453,"startTime":"0","endTime":"0","summary":"据《华尔街日报》报导,FDA要求诺瓦克斯公司完成COVID-19延迟注射的新临床试验路透4月25日 - 据《华尔街日报》周五援引熟悉内情的人士的话报导,在此前推迟批准Covid-19疫苗后,联邦监管机构要求Novavax NVAX.O完成额外的临床试验。(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nL4T3R31U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4547","NVAX","BK4568","BK4585"],"gpt_icon":0},{"id":"2530164896","title":"诺瓦瓦克斯医药盘中异动 股价大跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530164896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530164896?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 03:20","pubTimestamp":1745608845,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日03时20分,诺瓦瓦克斯医药股票出现波动,股价大幅下挫5.73%。截至发稿,该股报6.67美元/股,成交量431.707万股,换手率2.68%,振幅6.42%。机构评级方面,在所有7家参与评级的机构中,57%的券商给予买入建议,29%的券商给予持有建议,14%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.11%。诺瓦瓦克斯医药公司简介:诺瓦瓦克斯医药公司是一家从事疫苗开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426032045a6c86d26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426032045a6c86d26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","NVAX","BK4547","BK4568"],"gpt_icon":1},{"id":"2530702132","title":"Nanoviricides, Inc.盘中异动 股价大涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530702132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530702132?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 22:19","pubTimestamp":1745590784,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日22时19分,Nanoviricides, Inc.股票出现异动,股价快速上涨5.19%。截至发稿,该股报1.42美元/股,成交量4.7281万股,换手率0.30%,振幅2.89%。Nanoviricides, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。Nanoviricides, Inc.公司简介:Nanoviricides Inc是一家纳米生物制药公司,致力于发现、开发和商业化治疗剂,以推进对患有危及生命的病毒感染患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425221944aa2c7bb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425221944aa2c7bb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2530139608","title":"吉利德科学盘中异动 早盘股价大跌3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530139608?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 21:31","pubTimestamp":1745587905,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分,吉利德科学股票出现波动,股价快速下挫3.41%。吉利德科学股票所在的制药行业中,整体跌幅为0.18%。消息层面,截至21时31分,《吉利德科学首季扭亏为盈维持年度业绩预测》资讯为影响吉利德科学的重要信息。该信息摘要如下:吉利德科学在2023年第一季度实现了扭亏为盈,营收达67亿美元,净利润为13.15亿美元,优于市场预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213145a6c81d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213145a6c81d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4568","BK4578","LU0109394709.USD","LU2089984988.USD","LU0234570918.USD","LU1839511570.USD","LU2468319806.SGD","LU0889565916.HKD","BK4588","BK4550","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","BK4585","LU1066051498.USD","LU0320765992.SGD","LU1430594728.SGD","LU1066053197.SGD","BK4139","IE0002270589.USD","GILD","IE00B7SZLL34.SGD","LU1571399168.USD","BK4566","IE00B3T34201.USD","BK4532","IE00BZ1G4Q59.USD","LU1585245621.USD","BK4583"],"gpt_icon":0},{"id":"2530139775","title":"Equillium, Inc.盘中异动 股价大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530139775?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 21:31","pubTimestamp":1745587896,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分,Equillium, Inc.股票出现异动,股价快速跳水5.96%。Equillium, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。Equillium, Inc.公司简介:Equillium Inc是一家临床阶段的生物技术公司,致力于开发新的治疗方法,以治疗严重的自身免疫性和炎症性疾病,或免疫炎症性疾病,具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213136a6c81cfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213136a6c81cfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2530990724","title":"吉利德科学(GILD)第一季同比扭亏为盈至13.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530990724","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530990724?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 18:15","pubTimestamp":1745576112,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学(GILD)公布首季财报,按年扭亏为盈,录季度纯利13.15亿美元,对上财年同季录亏损41.7亿美元,主要涉及研发减值24.3亿美元及收购正进行研发所涉开支41.31亿美元拖累。季度每股摊薄纯利1.04美元,经调整后为1.81美元,略高于市场预期的1.79美元。季度收入按年跌不足1%至66.67亿美元,市场预期为68亿美元。公司爱滋病药Biktarvy销售按年升7%至31.5亿美元,符合市场预期。肝病药销售按年升3%至7.58亿美元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/YTEwMTc4Njg5ODk4OA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YTEwMTc4Njg5ODk4OA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","IE00BKVL7J92.USD","LU2087621335.USD","BK4550","IE00BZ1G4Q59.USD","BK4585","LU0109394709.USD","LU1839511570.USD","BK4568","BK4583","LU2468319806.SGD","GILD","BK4588","BK4578","IE00BSNM7G36.USD","BK4532","LU1066053197.SGD","LU1430594728.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU0889565916.HKD","LU0289739699.SGD","LU1066051498.USD","LU2089984988.USD","IE00B19Z3581.USD","LU0320765992.SGD","BK4566","LU0234570918.USD","LU0058720904.USD","BK4139","IE00B3T34201.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2530905116","title":"辉瑞英立达 获批国内首个且唯一晚期肾癌一线靶免联合治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905116","media":"21经济网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530905116?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 16:57","pubTimestamp":1745571434,"startTime":"0","endTime":"0","summary":"南方财经4月25日电,辉瑞公司今日宣布,其口服靶向药英立达?(Inlyta?,通用名:阿昔替尼片)于2025年4月22日获得国家药品监督管理局(NMPA)批准,联合特瑞普利单抗用于中高危的不可切除或转移性肾细胞癌(RCC)患者的一线治疗,这也是中国肾癌治疗领域首个且唯一获批的一线靶免联合治疗方案。(21世纪经济报道)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425171322a6c7d0d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0985481810.HKD","LU1066053197.SGD","BK4588","IE00BLSP4452.SGD","LU0456855351.SGD","LU0321505439.SGD","LU0289739699.SGD","PFE","LU0868494617.USD","SG9999001176.USD","BK4599","LU1883839398.USD","IE0002270589.USD","LU0225771236.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1894683264.USD","BK4585","LU0122379950.USD","BK4550","BK4581","LU0058720904.USD","LU0306806265.USD","LU0306807586.USD","SG9999001176.SGD","LU0321505868.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4534","SG9999003800.SGD","LU0234572021.USD","LU0170899867.USD","LU1894683348.USD","SG9999002224.SGD","LU1057294990.SGD","BK4592","LU1066051498.USD","BK4007","SG9999002232.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4568","SG9999011175.SGD","LU0225284248.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2530970288","title":"辉瑞:阿昔替尼获批中国首个且唯一晚期肾癌一线靶免联合治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2530970288","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530970288?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 16:55","pubTimestamp":1745571304,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BLSP4452.SGD","BK4599","LU0122379950.USD","IE00BBT3K403.USD","LU0306807586.USD","BK4585","LU0234572021.USD","BK4592","LU0321505868.SGD","LU0985481810.HKD","SG9999002232.USD","LU0170899867.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","BK4588","LU0868494617.USD","SG9999001176.SGD","PFE","IE000M9KFDE8.USD","BK4581","IE00B19Z3581.USD","LU0225771236.USD","BK4533","LU0058720904.USD","BK4568","RCC","IE0002270589.USD","LU1057294990.SGD","BK4550","LU1894683264.USD","BK4534","SG9999002224.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU1066053197.SGD","LU0321505439.SGD","LU0289739699.SGD","LU1894683348.USD","SG9999001176.USD","SGXZ57979304.SGD","SG9999003800.SGD","BK4007","LU0306806265.USD","LU1066051498.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"2530924793","title":"港股异动 | 和铂医药-B(02142)再涨超4% 公司与阿斯利康合作深化 已与多家MNC达成合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2530924793","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530924793?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 14:27","pubTimestamp":1745562446,"startTime":"0","endTime":"0","summary":"消息面上,和铂医药3月发布公告称,与阿斯利康订立全球战略合作协议,共同研发针对免疫性疾病、肿瘤及其他多种疾病的新一代多特异性抗体。太平洋证券指出,和铂医药已多次获得阿斯利康的青睐。和铂医药凭借3次合作,以及此次超45亿美元的潜在总交易金额,稳居阿斯利康中国BD交易榜首。除了阿斯利康之外,和铂医药还曾与辉瑞、艾伯维等多家MNC达成合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","02142","BK4007","BK4585","LU1829250122.USD","LU2417539215.USD","LU2456880835.USD","BK1583","BK4568","LU0889565916.HKD","LU2236285917.USD","AZN","LU2462157665.USD","BK1574","BK1161","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2530927861","title":"和铂医药再涨超4%公司与阿斯利康合作深化已与多家MNC达成合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2530927861","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530927861?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 14:27","pubTimestamp":1745562420,"startTime":"0","endTime":"0","summary":"和铂医药与阿斯利康深化合作,共建创新中心,并获得多家跨国药企青睐,凭借其专有技术平台不断发展。股价再涨超4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042514344894e20e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042514344894e20e10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU2417539215.USD","BK4568","LU2456880835.USD","LU1829250122.USD","BK4585","AZN","BK4007","LU2236285917.USD","LU0320765992.SGD","LU2462157665.USD","BK4588","LU0889565916.HKD","02142"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":176,"code":"91000000","status":"200"}]}}